New formulation

Details New formulation New formulation

A - Human Necessities

61

K

A61K 31/655 (2006.01) A61K 9/16 (2006.01) A61K 9/20 (2006.01)

Patent

CA 2283297

The invention provides a unit formulation which comprises a 2-hydroxy-5- phenylazobenzoic acid derivative which is particularly sodium balsalazide dihydrate which formulation has a density of at least 0.9 mg/mm3 and its use in the treatment of gastrointestinal diseases.

Cette invention concerne une formulation unitaire contenant un dérivé de 2-hydroxy-5-acide-phénylazobenzoïque qui est plus particulièrement du balsalazide sodique dihydraté. Cette formulation, dont la densité est au moins égale à 0,9 mg/mm?3¿, convient particulièrement au traitement des maladies gastro-intestinales.

Affiliated with

Also associated with

Rating

New formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1531507